Ohio allocates $3M to drugmaker creating abuse-proof opioid

Harrison Cook - Print  | 

Ohio will give Elysium Therapeutics $3 million in funding to develop a new class of opioids that cannot be abused, according to The Inquirer.

The initial funding represents a portion of the $20 million in grants Republican Gov. John Kasich requested to help create technological solutions to the opioid epidemic.

Ohio reported 4,050 overdose deaths in 2016 — 1,000 more than the prior year, according to the report.

"Our goal is to reduce the number of fatal overdoses," Greg Sturmer, CEO of Elysium Therapeutics told The Inquirer. He said Elysium will use the state's money to fund animal testing before moving on to clinical trials.

More articles on opioids: 

Opioid overdoses fuel declining US life expectancy: 3 things to know
Study: Opioid-free alternative targets immune system to relieve pain
Why states' opioid prescribing regulations may be a detriment to chronic pain patients

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.